Literature DB >> 7911881

Clinical application of apolipoprotein E genotyping to Alzheimer's disease.

A D Roses, W J Strittmatter, M A Pericak-Vance, E H Corder, A M Saunders, D E Schmechel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7911881     DOI： 10.1016/s0140-6736(94)92960-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

1.  Formaldehyde, Epigenetics, and Alzheimer's Disease.

Authors:  Fei Wang; Danqi Chen; Peipei Wu; Catherine Klein; Chunyuan Jin
Journal:  Chem Res Toxicol       Date:  2019-04-19       Impact factor: 3.739

2.  The number of trait loci in late-onset Alzheimer disease.

Authors:  E W Daw; H Payami; E J Nemens; D Nochlin; T D Bird; G D Schellenberg; E M Wijsman
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

3.  Clinical rationale of genetic testing in dementia.

Authors:  G B Frisoni; M Trabucchi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-03       Impact factor: 10.154

4.  Chronic Traumatic Encephalopathy in Athletes Involved with High-impact Sports.

Authors:  Cyrus Safinia; Eric M Bershad; H Brent Clark; Karen SantaCruz; Naila Alakbarova; Jose I Suarez; Afshin A Divani
Journal:  J Vasc Interv Neurol       Date:  2016-10

5.  Association Between Mentally Stimulating Activities in Late Life and the Outcome of Incident Mild Cognitive Impairment, With an Analysis of the APOE ε4 Genotype.

Authors:  Janina Krell-Roesch; Prashanthi Vemuri; Anna Pink; Rosebud O Roberts; Gorazd B Stokin; Michelle M Mielke; Teresa J H Christianson; David S Knopman; Ronald C Petersen; Walter K Kremers; Yonas E Geda
Journal:  JAMA Neurol       Date:  2017-03-01       Impact factor: 18.302

6.  Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City.

Authors:  M X Tang; G Maestre; W Y Tsai; X H Liu; L Feng; W Y Chung; M Chun; P Schofield; Y Stern; B Tycko; R Mayeux
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

Review 7.  Apolipoprotein E and Alzheimer disease.

Authors:  W J Strittmatter; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

8.  Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide.

Authors:  I Gozes; A Bardea; A Reshef; R Zamostiano; S Zhukovsky; S Rubinraut; M Fridkin; D E Brenneman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

9.  APOE genotype and functional outcome following aneurysmal subarachnoid hemorrhage.

Authors:  Matthew J Gallek; Yvette P Conley; Paula R Sherwood; Michael B Horowitz; Amin Kassam; Sheila A Alexander
Journal:  Biol Res Nurs       Date:  2008-11-17       Impact factor: 2.522

Review 10.  Apolipoprotein E and Alzheimer's disease: the implications of progress in molecular medicine.

Authors:  R Mayeux; N Schupf
Journal:  Am J Public Health       Date:  1995-09       Impact factor: 9.308
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.